-
1
Downregulation of Skp2 Expression Inhibits Malignant Phenotype of Osteosarcoma U2OS Cells
Published 2019-05-01Subjects: Get full text
Article -
2
Skp2 and its emerging role in the pathogenesis of systemic malignancies besides breast carcinomas
Published 2012-10-01Subjects: Get full text
Article -
3
Flavokawain B targets protein neddylation for enhancing the anti-prostate cancer effect of Bortezomib via Skp2 degradation
Published 2019-03-01Subjects: Get full text
Article -
4
PTEN loss promotes Warburg effect and prostate cancer cell growth by inducing FBP1 degradation
Published 2022-09-01Subjects: Get full text
Article -
5
Downregulation of decidual SKP2 is associated with human recurrent miscarriage
Published 2021-06-01Subjects: Get full text
Article -
6
Skp2 expression unfavorably impacts survival in resectable esophageal squamous cell carcinoma
Published 2012-05-01Subjects: Get full text
Article -
7
SKP2 Promotes Hepatocellular Carcinoma Progression Through Nuclear AMPK-SKP2-CARM1 Signaling Transcriptionally Regulating Nutrient-Deprived Autophagy Induction
Published 2018-07-01Subjects: “…SKP2…”
Get full text
Article -
8
Dioscin: A new potential inhibitor of Skp2 for cancer therapy
Published 2020-01-01Subjects: Get full text
Article -
9
SKP2 and OTUD1 govern non-proteolytic ubiquitination of YAP that promotes YAP nuclear localization and activity
Published 2018-08-01Subjects: Get full text
Article -
10
Inhibition of Skp2 Sensitizes Chronic Myeloid Leukemia Cells to Imatinib
Published 2020-06-01Subjects: “…skp2…”
Get full text
Article -
11
Phosphorylation by mTORC1 stablizes Skp2 and regulates its oncogenic function in gastric cancer
Published 2017-04-01Subjects: Get full text
Article -
12
Anti-tumor effects of Skp2 inhibitor AAA-237 on NSCLC by arresting cell cycle at G0/G1 phase and inducing senescence
Published 2022-07-01Subjects: Get full text
Article -
13
-
14
-
15
Lysosome‐dependent FOXA1 ubiquitination contributes to luminal lineage of advanced prostate cancer
Published 2023-10-01Subjects: Get full text
Article -
16
Silybin has therapeutic efficacy against non-small cell lung cancer through targeting of Skp2
Published 2022-08-01Subjects: Get full text
Article -
17
The Tubulin Inhibitor VERU-111 in Combination With Vemurafenib Provides an Effective Treatment of Vemurafenib-Resistant A375 Melanoma
Published 2021-03-01Subjects: Get full text
Article -
18
SKping cell cycle regulation: role of ubiquitin ligase SKP2 in hematological malignancies
Published 2024-03-01Subjects: Get full text
Article -
19
Antitumor activity of antisense oligonucleotide p45Skp2 in soft palate carcinoma cell squamous in vitro
Published 2013-03-01Subjects: “…Antisense p45Skp2 gene…”
Get full text
Article -
20
An Integrative Pan-Cancer Analysis Revealing MLN4924 (Pevonedistat) as a Potential Therapeutic Agent Targeting Skp2 in YAP-Driven Cancers
Published 2022-05-01Subjects: Get full text
Article